NCT01067560

Brief Summary

This study will determine the level of glucose (sugar) in the CSF (fluid that surrounds the spinal cord) in 30 subjects having spinal anesthesia for cesarean section using a bedside glucose meter. Spinal anesthesia is done by injecting drugs through a needle into the CSF. Subjects will have 1/10 tsp of CSF removed at the time of spinal anesthesia to measure the level of glucose. Glucose meters measure glucose, usually in the blood, and they can be used in the operating room. This study will see whether a glucose meter will easily measure the level of glucose in CSF.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 9, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 11, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

November 10, 2010

Status Verified

November 1, 2010

Enrollment Period

4 months

First QC Date

February 9, 2010

Last Update Submit

November 8, 2010

Conditions

Keywords

GlucoseCSFCesarean section, spinal anesthesiaNova Stat StripAbbott Precision XtraRoche Accucheck Inform 2

Outcome Measures

Primary Outcomes (1)

  • Primary Outcome is to establish reference ranges for glucose in CSF in parturients undergoing Cesarean delivery under spinal anesthesia using glucose meters currently undergoing testing at BC Women's Hospital

    1 day

Secondary Outcomes (1)

  • Our secondary objective is to compare the performance of glucose meters (bed side testing devices for glucose) to measure CSF glucose via three glucose meters (Nova Stat Strip, Abbott Precision Xtra and Roche Accucheck Inform 2).

    1 day

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Parturients undergoing Cesarean delivery under spinal anesthesia at BC Women's Hospital

You may qualify if:

  • Healthy women (American Society of Anesthesiologists (ASA) 1 or 2 classification) with a singleton pregnancy who are undergoing Cesarean section under spinal anesthesia.
  • Age 19 years or older
  • Understand written and oral English

You may not qualify if:

  • Women who are having an emergency Cesarean section
  • Women who are having epidural, combined spinal epidural or general anesthesia
  • Women who have a contraindication to spinal anesthesia
  • Women who are less than 19 years of age
  • Women with an abnormality of glucose metabolism such as diabetes mellitus, gestational diabetes
  • Women receiving dextrose intravenously prior to their surgery
  • Women in whom technical problems are anticipated during insertion of the spinal (such as scoliosis) ot who may have a hematological abnormality o If there is technical difficulty during insertion of the spinal there is an increased chance of trauma, resulting in blood entering the CSF (bloody tap). This could potentially be a source of glucose. Women with a hematological abnormality are at increased of bleeding which may increase the chance of blood in the CSF.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Women's Hospital, Department of Anesthesia

Vancouver, British Columbia, V6H3N1, Canada

Location

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, CSF

Study Officials

  • Giselle Villar, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Anne Catherine Halstead, MD, FRCPC

    University of British Columbia

    STUDY DIRECTOR
  • Simrat Saran, MD, BSc

    University of British Columbia

    STUDY DIRECTOR
  • Steve Thomas, MBChB, FRCA

    University of British Columbia

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 9, 2010

First Posted

February 11, 2010

Study Start

January 1, 2010

Primary Completion

May 1, 2010

Study Completion

June 1, 2010

Last Updated

November 10, 2010

Record last verified: 2010-11

Locations